PRCT
PROCEPT BioRobotics Corporation
Company Overview
| Mkt Cap | $1.85B | Price | $27.55 |
| Volume | 523.08K | Change | -5.00% |
| P/E Ratio | -19.4 | Open | $28.92 |
| Revenue | $308.1M | Prev Close | $29.00 |
| Net Income | $-95.6M | 52W Range | $19.35 - $66.85 |
| Div Yield | N/A | Target | $30.44 |
| Overall | 50 | Value | 55 |
| Quality | 65 | Technical | 30 |
No chart data available
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Latest News
PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), PROCEPT BioRobotics (PRCT) and Lineage Therap (LCTX)
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Incyte (INCY)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRCT | $27.55 | -5.0% | 523.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get PROCEPT BioRobotics Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW